William R Heath Selected Research

Simplexvirus glycoprotein B

5/2003	Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1.
1/2002	Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William R Heath Research Topics

Disease

30	Infections 11/2022 - 01/2002
16	Malaria 05/2022 - 02/2006
8	Virus Diseases (Viral Diseases) 01/2021 - 03/2002
8	Neoplasms (Cancer) 01/2021 - 05/2003
5	Inflammation (Inflammations) 10/2020 - 01/2002
2	Cerebral Malaria 06/2011 - 04/2009
2	Autoimmune Diseases (Autoimmune Disease) 05/2004 - 01/2002
1	Hypoxia (Hypoxemia) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2021
1	Lymphopenia (Lymphocytopenia) 12/2020
1	Chronic Disease (Chronic Diseases) 10/2020
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Leigh Disease (Leigh's Disease) 06/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Experimental Arthritis 06/2009
1	Human Influenza (Influenza) 02/2009
1	Herpes Simplex 02/2009
1	Carcinogenesis 06/2004
1	Skin Diseases (Skin Disease) 07/2003
1	Cytokine Release Syndrome 02/2003

Drug/Important Bio-Agent (IBA)

22	AntigensIBA 01/2021 - 01/2002
9	VaccinesIBA 01/2021 - 11/2007
6	Peptides (Polypeptides)IBA 05/2022 - 01/2002
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 05/2004
3	EpitopesIBA 01/2021 - 02/2003
3	CD40 Ligand (CD40L)IBA 12/2017 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 06/2004
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 06/2012
2	Viral AntigensIBA 01/2018 - 02/2003
2	OvalbuminIBA 02/2009 - 12/2007
2	LigandsIBA 02/2006 - 02/2003
2	Simplexvirus glycoprotein BIBA 05/2003 - 01/2002
1	Broadly Neutralizing AntibodiesIBA 11/2022
1	Conjugate VaccinesIBA 05/2022
1	CytokinesIBA 01/2021
1	hemozoinIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Interferon Type IIBA 12/2020
1	Dinoprostone (PGE2)FDA Link 10/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2020
1	ribosomal protein L6IBA 10/2020
1	RezafunginIBA 01/2020
1	GlycolipidsIBA 01/2020
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 03/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	AntibodiesIBA 03/2015
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 06/2012
1	IntegrinsIBA 05/2012
1	Granzymes (Granzyme)IBA 06/2011
1	Collagen Type II (Type II Collagen)IBA 06/2009
1	AutoantibodiesIBA 06/2009
1	ChemokinesIBA 04/2009
1	Chemokine ReceptorsIBA 04/2009
1	Interleukin-18 (Interleukin 18)IBA 12/2007
1	Interleukin-12 Subunit p40IBA 12/2007
1	Interferon-gamma (Interferon, gamma)IBA 12/2007
1	Interleukin-12 (IL 12)IBA 12/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2006
1	Antiviral Agents (Antivirals)IBA 02/2006
1	Glycoproteins (Glycoprotein)IBA 01/2004
1	Hemagglutinins (Hemagglutinin)IBA 05/2003
1	Gemcitabine FDA Link 05/2003
1	Indicators and Reagents (Reagents)IBA 05/2003
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2003
1	Immunodominant EpitopesIBA 05/2003
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 02/2003
1	Brefeldin AIBA 02/2003
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2002

Therapy/Procedure

3	Immunotherapy 03/2015 - 05/2003
1	Therapeutics 10/2020
1	Ligation 05/2004